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Repeated retroviral infections of vertebrate germlines have made endogenous retroviruses
ubiquitous features of mammalian genomes. However, millions of years of evolution obscure
many of the immediate repercussions of retroviral endogenisation on host health. Here we
examine retroviral endogenisation during its earliest stages in the koala (Phascolarctos
cinereus), a species undergoing germline invasion by koala retrovirus (KoRV) and affected by
high cancer prevalence. We characterise KoRV integration sites (IS) in tumour and healthy
tissues from 10 koalas, detecting 1002 unique IS, with hotspots of integration occurring in the
vicinity of known cancer genes. We find that tumours accumulate novel IS, with proximate
genes over-represented for cancer associations. We detect dysregulation of genes containing
IS and identify a highly-expressed transduced oncogene. Our data provide insights into the
tremendous mutational load suffered by the host during active retroviral germline invasion, a
process repeatedly experienced and overcome during the evolution of vertebrate lineages.
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Retrovirus-like elements are abundant in vertebrate gen-omes1, comprising 8% of the human genome. They origi-nate when exogenous retroviruses infect the host germline
and are subsequently inherited by offspring as endogenous ret-
roviruses (ERVs), some of which eventually reach fixation. Since
most mammalian ERVs derive from germline infections that
occurred millions of years ago, the early and most critical stages
of host–pathogen accommodation, including the immediate
effects on host health, remain unclear. Retroviruses are insertional
mutagens, affecting the host in multiple potentially deleterious
ways, including the disruption or alteration of gene expression2.
This makes the transition from a newly endogenised, active ret-
rovirus to a genomically fixed ERV a complex and dynamic
evolutionary process. The ongoing conflict between virus and
host (sometimes termed a retroviral “invasion” of the host
germline), unfolds over millions of years, during which time
proviruses can frequently reintegrate in the host genome causing
further germline mutations (de facto natural mutagenesis). The
proviruses will also undergo mutations which can ultimately
render them inactive.
The negative effects of exogenous retroviral infection of
somatic cells have been well characterised3,4. In addition, the
consequences of retroviral germline infection, where proviruses in
the germline (particularly gammaretroviruses) are subject to
Mendelian inheritance and are potentially active in every cell of
an individual, have been extensively studied in inbred and wild-
derived laboratory mouse strains5. Indeed much of the variation
between laboratory mouse strains is thought to be due to varia-
tion in the number and location of ERVs they possess5. Examples
of interactions of ERVs with their host’s genome include the
accumulation of new germline insertions6, the production of
active virus infections triggering oncogenesis7 and in some cases
recombination of defective ERVs to create new infectious
viruses8.
Given the mutagenic nature of retroviruses, a general con-
sequence of ongoing germline invasion is predicted to be
increased host cancer rates but this has not yet been directly
observed in outbred wild species7,8. Due to their oncogenic
potential, it is likely that intact ERVs will be strongly selected
against in favour of defective versions5. Evidence for such selec-
tion has recently been reported which shows that ERVs can be
rapidly degraded through recombination during the early stages
of germline invasion9. The host population will experience a
greatly increased mutational burden overall until all proviral
copies are attenuated.
The koala (Phascolarctos cinereus) provides a means of
studying the early stages of retroviral endogenisation in a wild,
outbred, large-bodied mammal. Koalas are currently undergoing
active germline invasion, a process which likely began in the last
50,000 years10. This recent germline infection is in contrast to
other species with unfixed ERVs, such as mice where the most
recent ERV group (murine leukaemia virus, MLV) entered the
genome ca. 1.5 million years ago11. The negative health effects on
koalas caused by this invasion are also of interest and concern
from a conservation perspective for this iconic and vulnerable
species. The koala retrovirus (KoRV-A)12 is endogenous in all
koalas from northern Australia, but some southern koalas are
believed to remain unaffected as the virus has spread from north
to south13. Other KoRV variants (designated KoRV-B through
KoRV-I)14–16 have also been detected but are presumed to be
exogenous (infecting only somatic cells and transmitted hor-
izontally). Endogenous KoRV-A may also produce infectious
virus particles and be spread horizontally as well as vertically13,17,
though the evidence is correlative, and blocking of the receptor18
by endogenous KoRV-A may limit exogenous retroviral spread if
it does occur in vivo.
KoRV is a member of a retroviral lineage associated with
lymphoma and leukaemia19, both of which occur with remark-
ably high prevalence in koalas. In the wild, nearly 3% of mature
northern koalas are affected by lymphoma20,21 (which is at least
an order of magnitude higher than in humans) and over 7% suffer
from lymphoid neoplasms21. In a study of captive koalas, 25%
developed lymphoma, with a potential hereditary pattern of dis-
ease observed in some facilities22. Lymphoid neoplasms are
associated with high KoRV viral loads and are seen at a higher
rate in northern populations21,23. Many other benign and
malignant tumours are also observed such as osteochondromas,
which affect 2–4.5% of northern koalas20–22, mainly occurring in
the skull and resulting in death through compression of organs.
Here, we show that northern koalas harbour ca. 80–100
inherited proviral copies in their germlines, none of which are
fixed across the population and few of which are shared between
individuals. Shared integration sites (IS) correspond to the geo-
graphical proximity of the koalas, and also suggest a possible
KoRV-mediated predisposition to tumours. We find that tumour
tissues accumulate somatic KoRV integrations which are sig-
nificantly associated with genes involved in cancer. In one koala,
we detect a KoRV provirus that has transduced a host oncogene,
with the oncogene displaying markedly increased expression.
Finally, we find genomic hotspots of KoRV integration in
proximity to genes associated with cancer.
Results
Detection of KoRV IS in healthy and tumour tissue. We
characterised KoRV IS in both tumour and healthy tissues from
ten koalas from northern Australia. Details of the koalas, their
diagnoses and the tissues used are provided in Supplementary
Table 1. IS detection was carried out using a technique involving
DNA sonication, inverse PCR (iPCR) and subsequent PacBio
sequencing which we term SIP (for sonication iPCR)24. This
generated long sequence reads (Supplementary Table 2) which
span the regions of the koala genome flanking each IS and the
adjoining proviral sequences (Supplementary Fig. 1). Mapping
the reads to the koala genome (release version 4.1) allowed us to
precisely identify the genomic position of each IS (Supplementary
Fig. 2). A total of 1002 distinct IS were detected in the ten koalas
(a full list is provided in Supplementary Data 1). Studies of KoRV
have been facilitated by assembly of the koala genome25. Other
more ancient ERVs are reported as rare in the koala genome
(~1% of the genome) compared to other mammals, e.g. human,
gorilla and mouse, where 8–12% of their genomes are composed
of ancient ERVs. In general, Australian marsupials and mono-
tremes are reported to contain a very low percentage of ERVs25,
likely due to their geographical separation from species that act as
retroviral reservoirs.
In each koala, the majority of IS were common to both healthy
and tumour tissues (overall, 786 of the 1002 IS) (Fig. 1,
Supplementary Table 3). The fact that most IS were indepen-
dently identified in both healthy and tumour tissues indicates that
IS detection using our SIP method24 was close to saturation.
Moreover, all shared IS were found in both tissues of all koalas
that shared the IS (if saturation had not been reached, IS would be
missing in some tissues). Overall, false positives and negatives are
unlikely to impact our findings (see Supplementary Figs. 1–3 for
further details).
ERVs are present in all cells of an individual, being inherited in
a Mendelian fashion. We found, on average, 100 KoRV ERVs per
koala. This is in line with the number of KoRV proviruses found
in the koala reference genome which has 98 KoRV ERVs, 65 of
which are intact, full-length KoRV-A sequences26. Since the
reference genome contains 65 intact copies of KoRV-A and
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KoRV genes are expressed in koalas27, it is plausible that some
KoRV proviruses retain the potential to reintegrate (through
reinfection or possibly retrotransposition), leading to further
germline and/or somatic integrations. Therefore, in each of our
koalas, some KoRV ERVs are likely to retain the ability to
reintegrate and could potentially affect host gene expression. The
majority of KoRV ERVs (79%) were not shared among the koalas
examined. The lack of sharing of IS is reminiscent of inbred lab
mouse strains where the formation of novel IS can occur, though
at a very much lower rate than that seen in koalas28, but contrasts
with older ERVs of vertebrates including those in humans which
are generally found in all individuals at the same respective
genomic loci. In koalas, the lack of fixed IS and the limited
number of IS shared between individuals reflects the early stage of
host germline invasion by KoRV and indicates a rapid expansion
and accumulation of new IS across the northern koala population.
It is not yet known whether new KoRV-A integrations are the
result of (i) retroviral integration of a virus produced by an ERV
in an individual; (ii) intracellular retrotransposition of an ERV; or
(iii) new retroviral infection of an exogenous KoRV-A virus.
However, in mice, active ERVs have been shown to produce
infectious viruses from birth and generate new proviruses by
infecting the oocytes of offspring in utero6.
KoRV-A and other KoRV variants were identified in our
samples (Supplementary Table 4), with KoRV-A being by far the
predominant subtype. Other subtypes are thought to be
exogenous and thus present in a small proportion of host cells,
so that KoRV-B, KoRV-D and KoRV-F represent only a tiny
fraction of reads detected in any sample29. KoRV-B, which has
been associated with cancer in a US zoo15, was found in only two
of the koalas (Kathy and Butler) and therefore does not explain
most of the observed neoplasms. Moreover, this variant of KoRV-
B lacked the expanded repeats in the LTRs and the CETTG motif
(shown to be more pathogenic than the CETAG/CGTAG motif
present in KoRV-A) found in the zoo koalas. In this study, we
have used the term KoRV to represent all insertions, recognising
that nearly all IS in northern koalas are KoRV-A derived
integrations, with a small number potentially arising from other
KoRV variants.
Tumour-specific IS show an association with cancer genes. Of
the 1002 IS characterised, 172 IS were detected exclusively in
tumour tissues (“tumour-unique IS”) (Fig. 1). These are somatic
integrations that are the result of retroviral genomic reintegration
followed by clonal expansion of the tumour cells. The presence of
tumour-specific IS was not attributable to sequence coverage
differences (Supplementary Fig. 3), and the tumour specificity of
a subset of these IS was verified by PCR (Supplementary Fig. 4). A
further 37 IS were detected exclusively in healthy tissues which
represent other non-cancer-related somatic reintegration events
(14 of these occurred in a single koala, Kathy) (Supplementary
Table 3).
Four koalas with malignant neoplasms showed an accumula-
tion of IS in tumours, with over 20 tumour-specific IS each.
Tumour-specific IS were found more often than expected in
exons (Supplementary Fig. 5), although these were mainly non-
coding exons (Supplementary Table 5), including the 5′ UTRs of
cancer-related genes BCL2, IL6R, KRT13 and TRAF4. To
investigate possible retroviral-mediated dysregulation of host
genes, we selected the gene closest to each IS as a way to generate
an unbiased gene set. Just under half (45.5%) of the 1002 IS are
located within genes, and of the remainder, 74.5% are within 1 kb
of a gene and 91% are within 50 kb. In each case, we determined
the closest host gene, regardless of orientation. Although genes
close to IS are the most likely to affected by retroviral-mediated
dysregulation, longer range interactions and trans-interactions
are possible30. The set of genes closest to tumour-specific IS were
significantly enriched in KEGG pathways31 for cancer and Ras
signalling, and in GO terms32 for leukocyte and lymphocyte
differentiation (P < 0.05). There was also significant enrichment
Fig. 1 Overview of IS detected in healthy and tumour tissues of ten koalas. The name and sex of each koala is given, with age and year of birth in square
brackets (age and year of birth are estimated from tooth wear). Number of IS detected in all tissues are shown in green for each koala and represent ERVs,
whereas tumour-specific IS (shown in orange circles) represent somatic integrations in tumour tissues. Koalas sharing many IS are grouped (see Fig. 3),
with the numbers of shared IS given in blue boxes (dark blue= total IS shared, including IS shared with other koalas; light blue= IS shared only between
given koalas; lines connect koalas that share IS and do not represent specific family relationships). Outside of these groups, koalas share nine or fewer IS.
Examples of genes containing IS shared only between indicated koalas are given (with genes containing IS in exons shown in boldface).
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in disease gene sets (from DisGeNET33) related to leukaemia and
lymphoma (P < 0.01), including proto-oncogenes such as BCL2
and MYC (Table 1, Supplementary Table 6). Tumour-specific IS
also showed two-fold enrichments in three out of five cancer gene
datasets (Supplementary Table 7). Enrichments were found even
though many genes in koala are not yet fully annotated. The
mechanisms which may bias the genomic positions of retroviral
integration are complex; however, for gammaretroviruses such as
KoRV it appears likely that regions of active transcription are
particularly accessible to retroviral insertion34. Thus, while
cancer-related genes are not necessarily preferential KoRV IS,
they are transcriptionally active genes playing general roles in
cellular homoeostasis, growth and proliferation and are therefore
likely to be accessible for gammaretroviral integration. This IS
preference is likely mediated by interactions between the viral
integrase and host proteins (e.g. bromodomain and extraterminal
domain proteins35). To examine whether there was a propensity
for tumour-specific IS to be located near genes with higher
expression, we used published RNA-seq data from koala lymph
nodes36 and found a small but significant shift towards higher
expression levels for the set of genes closest to tumour-specific IS
(P= 0.005) (Supplementary Fig. 6). Furthermore, tumour devel-
opment likely elicits a selection process favouring cells containing
new, somatic KoRV IS that promote their propagation and
survival in a similar way to what has been observed in MLV and
HIV-1 infections37,38, leading to selection (clonal amplification)
of IS in the vicinity of such genes.
KoRV IS can dysregulate genes. To examine whether KoRV IS
can induce gene dysregulation, we measured expression levels of
genes containing tumour-specific IS in introns. We chose genes
containing the highest coverage tumour-specific IS for testing
(Supplementary Table 8 and Supplementary Fig 7). Using
quantitative RT-PCR, we compared the expression of each gene
in the tumour tissue of the koala with the IS to the same tissue
type in other koalas lacking the IS. We used same tissue type to
avoid among tissue variation in expression (likely to be greater
than among animal variation) as a potential confounder. Gene
expression could not be directly compared between healthy and
tumour tissues in the same individual as distinct tissues were
intentionally collected for each koala to ensure tumour-specific IS
were identified (and some of the tumour types in this study were
of diffuse phenotype meaning healthy matched tissue from the
same organ was not available). Two additional zoo koalas were
included as controls (Supplementary Table 9). These two koalas
derived from a northern koala population and both died of old
age (a reasonable control for the disease cohort with 40% aged
animals). We found that for four of seven genes tested, expression
was higher in the sample containing the tumour-specific IS
compared to control tissues lacking the IS, indicating that the IS
may be responsible for the change, with 4–97-fold increases (P <
0.05 for each comparison). Such changes in expression of proto-
oncogenes are one mechanism by which KoRV integrations could
promote tumourigenesis, malignant transformation and pro-
metastasis pathways, consistent with other gammaretroviral dri-
ven expression changes38.
KoRV can transduce oncogenes. Retroviruses can acquire and
transduce host genes (e.g. Rous sarcoma virus39, mouse
gammaretroviruses8,40). We found evidence that this may be the
case for KoRV. In one koala (Kathy), a KoRV sequence was
identified in which the retroviral envelope gene was almost
entirely replaced by the complete, in-frame coding sequence for
the koala gene BCL2L1 (Fig. 2b, Supplementary Fig. 8). There are
two known isoforms of BCL2L1, a long (Bcl-XL) and a short (Bcl-
XS) form, which act as an apoptotic inhibitor41 and an apoptotic
activator, respectively42. The fusion gene contained the long
isoform, Bcl-XL, overexpression of which has been found to play a
pivotal role in invasion of various malignant neoplasms in other
species43. In Kathy, expression of BCL2L1 was found to be >500-
fold greater than in other koalas (P= 0.00004) (Fig. 2a). Kathy
suffered from anaplastic carcinoma of thyroid origin and copy
number variants of BCL2L1 have been found in this cancer
type44. The transduced KoRV also contained part of the 3′ UTR
of the koala gene ZBTB18.
We identified the IS associated with this transduced KoRV in
Kathy and found six low coverage IS, five of which were specific
to healthy tissue and one specific to tumour. This suggests
multiple somatic integrations have occurred. Other somatic IS
with very low read coverage may exist for the transduced KoRV,
but these are difficult to detect. Overall, Kathy had the highest
number of IS specific to healthy tissue (a total of 14), higher than
the other koalas (which had from 0–5), indicating an abundance
of somatic integrations in Kathy (Supplementary Table 3). The
fact that the transduced KoRV has multiple, low coverage, tissue-
specific integrations suggests that it may be exogenous. The
variable parts of the LTRs and envelope protein that are used to
define different KoRV strains are missing from the transduced
KoRV, but the start of the LTR shows highest sequence identity to
KoRV-A (98.5% across 203 bp).
Table 1 Gene enrichments for sets of genes closest to tumour-specific IS.
DisGeNET P OMIM disease P KEGG pathways P GO terms P
Leukemogenesis 7.99E-06 Leukaemia 0.066 Pathways in cancer 0.006 Leukocyte differentiation 0.013
Precursor cell lymphoblastic
leukaemia lymphoma
5.20E-04 Lymphoma 0.260 Small cell lung cancer 0.019 Lymphocyte
differentiation
0.020
Blood basophil count 7.91E-04 Protein C deficiency 0.843 Ras signalling 0.022 Lymphocyte activation 0.097
Eosinophil count result 0.0016 Rheumatoid arthritis 0.983 cGMP-PKG signalling 0.310 Regulation of response to
stimulus
0.162
Eosinophil count procedure 0.0019 Gastric cancer 1.000 Kaposi sarcoma-associated
herpesvirus infection





0.0019 Dementia 1.000 JAK-STAT signalling 0.314 Regulation of ossification 0.229
Carcinogenesis 0.0020 Ovarian cancer 1.000 Chronic myeloid leukaemia 0.321 Calcium-mediated
signalling
0.256
We looked at and disease genes from OMIM (https://omim.org/) and DisGeNET33, KEGG pathways31 and GO ontologies32. P values are from Enrichr76 (calculated using Fisher’s exact test and adjusted
for multiple testing).
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We found some evidence that a similar gene transduction is
also present in Elise at low titre. The gag gene of the transduced
KoRV from Kathy also contained part of the 3′ UTR of the koala
gene ZBTB18 and this sequence was also found within the gag
gene in reads from Elise; however, the BCL2L1 sequence was not
found in reads from Elise. Being one of the earliest collected
samples, Elise had the shortest read lengths (due to DNA
degradation over time) and so sequences at a greater distance
from LTRs were less likely to be amplified during our iPCR
procedure. Using primers specific to ZBTB18 and BCL2L1, we
amplified the ZBTB18–BCL2L1 spanning region in Elise (using
other koalas as controls), and sequencing confirmed the presence
of BCL2L1 although the junctions were not the same and this
version appeared to be highly mutated compared to the version
identified in Kathy (Supplementary Fig. 9). Although the data
from Elise does not show that the transduced KoRV in Kathy is
infectious, the low coverage, tissue-specific IS in Kathy suggest
that the transduced virus may have been transmitted by infection.
Further studies are required to confirm this. Although transduced
retroviruses generally cannot promote infection by themselves
due to loss of essential genes, they can be spread by infection
using viral proteins produced by other intact proviruses within
the cell39.
Shared ERVs near oncogenes may predispose koalas to cancer.
Of 1002 IS identified, 793 were present in both healthy and
tumour samples, and represent ERVs. Each koala carried 86–117
KoRV ERVs, some of which may have the potential to contribute
to gene dysregulation throughout the life of the koala. The set of
3’ UTR truncated Bcl-XL protein 4.7 kb of gag/pol 
deleted 
450 bp insertion, similar to 
3’ UTR of ZBTB18 
UTR 
1425 bp of env 
replaced by BCL2L1 
gag-pol env env UTR LTR LTR exon 2 BCL2L1   exon 1 
a 
b
tumour with IS 
tumour, no IS 
healthy ssue 
Fig. 2 qPCR expression of genes containing tumour-specific KoRV IS and structure of KoRV containing transduced oncogene. a Expression of a set of
genes containing tumour-specific IS. Quantitative PCR expression levels (ΔΔCt values83) are shown, per gene, for tumour tissue from the individual with
the tumour-specific IS (square icon), and for tumour (triangles) or healthy tissues (circles) from other koalas (colour-coded). All qPCRs were performed in
triplicate and the mean used for analysis. Boxplots indicate the interquartile range (IQR) with the centre line showing the median; whiskers show 1.5 × IQR.
Two zoo koalas (Bilyarra and Mirali) not collected for the study of neoplasms were also used as controls, with Bilyarra used as a baseline for ΔΔCt values
(i.e. for each gene all ΔCt values were divided by that of Bilyarra, so Bilyarra does not appear in the graph). Genes with significant changes in expression
were: RASSF2 (P= 0.0023), RNF216 (P= 0.0096), KIF26B (P= 0.0015) and TIAM2 (P= 0.0425) based on t tests of ΔCt values. The expression of the
transduced oncogene BCL2L1 (Bcl-XL) shown on the right side of the graph was also significantly increased (P= 0.0004). The expression levels of BCL2L1
were 500-fold higher in Kathy than the other koalas tested (fold change calculated as 2−ΔΔCt). b Structure of the KoRV containing transduced BCL2L1
detected in Kathy. The two BCL2L1 exons are joined together precisely at the splice junction and are flanked by the beginning and end of the KoRV env gene.
The BCL2L1 3′ UTR joins the 5′ and 3′ ends of env via micro-homologies (CAG and CCTCCC, respectively). Most of gag and pol are also replaced by a
sequence similar to the 3′ UTR of koala gene ZBTB18.
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genes proximate to these IS was significantly enriched in two
datasets of cancer genes (Supplementary Table 7), including
cancer drivers (genes such as BRAF, PIK3R1, RELN and TIAM2)
suggesting that some koalas may harbour ERVs that could confer
increased cancer susceptibility. We also found that the top Dis-
GeNet enrichment for this set of genes was for body mass index
(P= 0.0034), indicating that ERVs are not as strongly associated
with cancer genes as tumour-specific IS.
Endogenous IS are subject to gene flow and we found that 20%
were present in more than one koala (Fig. 3a). All shared ERVs
were found in both tissues of all koalas that shared the ERV,
indicating the accuracy of ERV detection in our dataset. Only one
IS was common to all of the koalas, located in an intron of the
gene SLC29A1. This IS is also present in the koala reference
genome. SLC29A1 is a highly conserved nucleoside transporter
which also plays a role in the transport of xenobiotics45.
SLC29A1-null mice have a significantly lower body weight than
wild-type litter mates46 and low expression is associated with
poor prognosis in patients with hepatocellular carcinoma47.
Using published RNA-seq data36, we found that this gene had
significantly higher expression in northern koalas compared to
southern (Fig. 3b) suggesting that the intronic IS has an effect on
expression of SLC29A1. The presence of this ERV in all koalas
examined suggests that it does not have a highly detrimental
effect. No other IS was shared to the extent of SLC29A1; other
shared IS were present in no more than five koalas, and the
majority of IS were unshared.
Principal component analysis and clustering identified groups
of koalas based on shared IS (Fig. 3c, Supplementary Fig. 10).
These groups corresponded to the geographic provenance of the
koalas (Fig. 3d), with the number of shared IS decreasing
exponentially with distance (a Mantel test demonstrated a strong
negative correlation: r=−0.86; P= 0.0007 (Fig. 3e)). This is
consistent with the fact that koalas do not generally disperse over
large distances. Within these PCA groups, koalas shared up to 43
IS (mean= 26.8) compared to nine or fewer (mean= 4.3) outside
the groups (Fig. 1). Also, within the groups, we found 4.9% of
shared IS were located within an exon (mainly UTRs)
(Supplementary Table 10), whereas only 1.1% of IS shared by
geographically separated groups were located in exons (Fig. 3a)
suggesting that IS within exons are less likely to propagate widely
throughout the population. There was some correspondence
between the PCA groupings of the koalas and the diagnosed
tumour types, despite some koalas being collected up to 10 years
apart. For example, koalas Ralf and Elise both suffered from
lymphoma/leukaemia and shared an IS in the 5′ UTR of ZFAT, a
gene implicated in hematopoietic malignancies47. This IS was also
shared by the reference genome (a female koala named Bilbo).
RNA-seq data exist for Bilbo from a study of chlamydial eye
disease, and using these data, we examined gene expression
around the IS in ZFAT in Bilbo and 29 other northern koalas. We
found that Bilbo and two other koalas had markedly increased
expression in ZFAT (~5–8-fold higher) (Supplementary Fig. 11).
All three koalas were collected within a ~24 km geographic
radius; Ralf and Elise were the only two of our samples to also
originate in this area. The increase in gene expression was found
to start exactly at the position of the IS and continue throughout
the ZFAT gene suggesting that this IS increases expression of
ZFAT. In another PCA grouping, all three koalas (Bonnie, Butler
and Donovan) developed tumours in the head and neck and
shared a single exonic IS in the 3′ UTR of LSAMP, a gene that is a
candidate tumour suppressor in human osteosarcomas48. We
hypothesise that inherited IS in or near proto-oncogenes could
predispose affected individuals to certain cancers, but a larger
dataset would be needed to confirm this. Overall, ERVs that have
propagated widely throughout the koala population are less likely
to have a negative effect on the health of koalas, but it is possible
that deleterious ERVs are inherited within groups of related
koalas, particularly when the detrimental effects occur after sexual
maturity.
Hotspots of KoRV IS are located in regions containing known
cancer genes. The complete set of 1002 IS detected were not
distributed evenly across the genome and were found to be more
often located within 10 kb of each other, at a frequency higher
than expected by chance (17% of IS compared to 6.2% when
positions were randomised maintaining same number of IS per
scaffold, P < 0.0001). We used a Monte Carlo simulation method
that has been previously described38 to determine the distribution
of IS that would occur by random chance in various window sizes
across the koala genome. The top seven regions of significant IS
density are listed in Supplementary Table 11. These regions
contain a total of 28 ERVs and 7 somatic IS. Three of these
regions (Fig. 4) contained genes previously associated with cancer
through insertional mutagenesis screens in mice (AHI149,
PPFIBP150 and TM9SF251). In such mutagenesis screens, genes
involved in tumour progression are detected by the presence of
multiple, independent somatic IS, with transformation most fre-
quently induced through dysregulation of gene expression by the
viral promoters52. AHI1 expression is highly elevated in certain
human lymphoma and leukaemia stem/progenitor cells53 and
TM9SF2 has been linked leukaemia54. PPFIBP1 (liprin β1)
interacts with metastasis-associated protein S100A455 and has
been associated with tumour progression in patients with high-
grade chondrosarcomas56 (a malignant transformation of osteo-
chondroma). The other hotspot regions also contained genes
associated with cancer, including SPOCK1 (Testican-1), which
promotes growth, invasion and metastasis in several cancers57,58
including osteosarcoma59, and the proto-oncogenes MYB and
MYC, which are frequently aberrantly expressed in leukaemias
and lymphomas60,61. There were three independent integrations
very close to the MYC transcription start site (clustered within
624 bp, within <1300 bp of MYC). Two of these were in healthy
tissue and one was tumour specific. Therefore, it appears that IS
with a high potential for inducing tumorigenesis can be present in
all tissues. Since retroviral integrations can influence the tran-
scriptional activity of nearby genes (on both strands), the hot-
spots of KoRV integration in regions containing cancer-related
genes could be one factor predisposing koalas to developing
tumours.
In several of the hotspots, we found that the majority of koalas
contained at least one IS within the region. For example, eight
koalas had at least one IS in the dense region of IS upstream of
CLYBL (Supplementary Fig. 12). Moreover, some of the hotspots
contained IS that were widely shared among koalas, and so have
been subject to inheritance unlike the somatic IS detected in
mouse mutagenesis screens. It is possible that a small number of
IS may be selected for favourable effects in early life, while also
playing a role in tumour development at a later stage, a process
known as antagonistic pleiotropy62. For example, the region with
the most significant density of IS is located between the genes
CLYBL, which is required for vitamin B12 metabolism63, and
TM9SF2, which has been associated with leukaemia54. Other
genes in hotspots that have cancer associations might also confer
positive effects. For example, SPOCK1 and AHI1 have associa-
tions with obesity64,65 and feeding behaviour65 and PPFIBP1
plays an important role in the integrity of lymphatic vessels66,
which are responsible for the uptake of dietary fat and fat-soluble
vitamins. Since koalas have a nutritionally poor diet (eucalyptus),
it is possible that KoRV IS, which upregulate genes involved in
vitamin uptake or metabolism, and body weight or feeding
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behaviour could be beneficial even if there may be detrimental
effects later in life.
Discussion
We provide insights into the ongoing retroviral invasion of the
koala genome, focusing on the potential of KoRV to underlie the
high cancer rates in the northern koala population. Using a
method to accurately and comprehensively detect KoRV IS, we
examined both tumour and healthy tissues from ten koalas,
allowing us to detect KoRV ERVs and somatic integrations in
tumour tissues. We find that northern koalas carry a high
mutational burden from a rapid expansion and accumulation of
endogenous KoRV integrations in the population. All koalas in
the northern population likely carry similar numbers of KoRV-A
proviruses67 with some proviral IS possibly conferring a higher
cancer risk than others. It is also clear that this germline muta-
tional load is compounded in individual koalas by substantial
accumulation of somatic integrations. We find evidence that
KoRV can induce gene dysregulation of proximate genes, both as
an ERV and following somatic integrations. The inherited KoRV
ERVs present in all tissues provide a pool of proviruses in every
cell, from which new somatic integrations or gene transductions
could potentially occur, with some somatic reintegration events
potentially affecting oncogenes. KoRV-mediated dysregulation of
oncogenes may cause cells to clonally expand resulting in our
CTNNBL1, MAP4K4, RCAN2 
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Fig. 3 Sharing of KoRV IS. a Numbers of IS unique to one koala (either tumour-specific IS or IS in healthy tissue in a single koala) compared to those
shared in PCA groups (shown in c). The single IS shared by ten koalas is located in the gene SLC29A1, an equilibrative nucleoside transporter. The three IS
shared by five koalas were located 1 kb downstream of MAP4K4, in a 140 kb region between the genes CTNNBL1 and SRC, and in an intron of RCAN2. Insert
shows percentages in the categories according to genomic location. Shared (other) refers to all IS shared between two or more koalas that are not in PCA
groups. IS shared within the PCA groups are more likely to be in exons that those shared outside the groups. b From published RNA-seq data36, the
expression of SLC29A1 in lymph nodes was found to be differentially expressed in northern koalas from Queensland (QLD) compared to koalas from South
Australia (SA); this was the most significantly differentially expressed annotated gene between the two koala populations (using the Limma R package86
for differential expression analysis with false discovery rate used for multiple test correction: log fold change= 3.65, P= 1.35 × 10−5). Boxplots indicate the
interquartile range (IQR) with the centre line showing the median; whiskers show 1.5 × IQR. c Sharing reflects the geographic proximity of the koalas with
principle component analysis showing groups which correspond to proximity. Note: PCA analysis was carried out without prior knowledge of the
geographic origin of each koala and led us to request the location data of the samples. d Provenance of the koalas shown on a map of coastal region
bordering Queensland and New South Wales, Australia (~130 km north and south of Brisbane is shown). e Plot of number of shared IS versus geographical
distance with pairs of koalas sharing the highest numbers of IS highlighted.
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observed enrichment of tumour-specific integrations near onco-
genes. In addition, we find that KoRV is able to transduce host
oncogenes, potentially resulting in a transforming virus that could
be transmissible, which would be of concern for koala con-
servation efforts. Although other factors may also contribute to
cancer in koalas, the mutational burden from endogenous KoRV
likely increases the frequency of tumorigenesis and may poten-
tially shorten the time for cancer to develop (Fig. 5).
Koalas and KoRV represent one of the youngest germline
invasion processes observed in mammals (<50,000 years)
demonstrating the effects on the host at the earliest stages of the
process, when the exogenous retroviruses and ERVs are biologi-
cally most similar. In most other mammalian species, ERVs are
derived from germline invasions that occurred millions of years
ago, so that host genomes now only contain ERVs that are fixed
and inactive. A notable exception to this are MLVs in wild and
laboratory mouse strains which remain capable of expression and
replication even after ~1.5 million years within the host gen-
ome11. However, the variation in MLV insertion number, loca-






Fig. 4 Regions with significantly high IS density (hotspots) in the koala genome. IS locations are shown with arrows. Regions longer than the identified
hotspot windows are displayed to show the surrounding genes; locations of hotspots are indicated by thick back line on contig scale bar. Long non-coding
RNAs are labelled “lnc” and genes without annotation are unlabelled. All regions contain multiple IS that are found in both healthy and tumour tissue
(ERVs) (red arrows). Regions (a–c) contain IS that are conserved in multiple koalas (purple arrows). Regions (a, d, e) contain tumour-specific IS (pink
arrows). All regions contain genes with associations to cancer, namely a, TM9SF2; b, PPFIBP1; c, SPOCK1; d, AHI1 and MYB; e, MYC. There may also be
positive benefits for increased expression of some genes in these regions; for example, a also contains a gene involved in vitamin metabolism (CLYBL), and
the cancer genes PPFIBP1, SPOCK1 and AHI1 in regions b–d, respectively, have roles in body weight and feeding behaviour. Two other identified hotspots are
not shown here because they were not in close proximity to protein coding genes: one was surrounded by non-coding RNAs and the other was at the very
start of a contig (see Supplementary Table 11).
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probably reflecting, in part, the increased time frame of associa-
tion of MLVs with their host. In species with much older ERVs
(e.g. human ERVs68), the mutational load of these ERVs appears
to be very low and few are linked to cancer in individuals.
In koalas, which have very high cancer rates for mammals, the
KoRV-A induced mutational load should over time be purged, in
part by their gradual degradation through mutation or recom-
bination9, with degraded ERVs having a less detrimental impact
on the health of the host. It is these degraded ERVs that are likely
to persist and become fixed in the genome. However, koalas are at
such an early stage in the endogenisation process10 that the tip-
ping point at which the exogenous retroviral counterpart becomes
extinct, degraded retroviruses cease to genomically proliferate,
and subsequent genomic fixation occurs may not be reached for
hundreds of thousands of years. Surviving retroviral endogen-
isation also involves the host genome accommodating the
endogenous retroviral content or mitigating its effects, con-
tributing to the evolution of host viral suppression mechanisms,
for example, piRNAs69 or APOBEC3G70.
Overall, the newly endogenised retroviral content substantially
affects the host genome in multiple ways, not only with strong
selection pressure likely arising due to negative health effects but
also with ERVs contributing new genomic sequence such as
promoters, and even providing some beneficial effects71. This
renders the evolutionary dynamics between virus and host
complex. The profound evolutionary consequences of germline
invasions have shaped vertebrate genomes and have been
repeatedly experienced during vertebrate evolution, including the
lineage leading to modern humans. However, the immediate
health effects on a species, including increased cancer rates, must
first be endured and overcome.
Methods
Sample collection. Koalas are a vulnerable species and northern koalas in parti-
cular suffer from multiple widespread diseases (e.g. KoRV related wasting, endemic
chlamydia and cancer) and are also prone to injuries (dog attacks and road acci-
dents) and so are regularly admitted to dedicated wildlife facilities for treatment
and rehabilitation. The koalas included in this study were admitted to dedicated
wildlife treatment and rehabilitation centres after being rescued from the wild for
overt illness (e.g. large tumours, wasting). All treatment facilitates perform thor-
ough and consistent veterinary examination and diagnostic procedures on all
admissions. Note: koalas are given unique identification numbers at admission but
are also commonly named for ease of identification by the veterinary team. After
undergoing thorough diagnostic procedures under general anaesthetic performed
by highly experienced wildlife veterinarians, koalas were diagnosed with advanced/
untreatable neoplasia. Due to the serious and untreatable nature of their condition,
koalas were humanely euthanised by the veterinary team via intravenous injection
of pentobarbitone (0.5 ml/kg). After confirmation of death (listening for cessation
of heartbeat), the koalas were promptly necropsied and tissue samples were col-
lected during routine post mortem procedures by the onsite wildlife veterinarian.
Individual tissues of interest were collected for histopathology (5–8 mm in size put
into 10% buffered formalin) and immediate freezing (−80 °C) for later assessment.
Sample collections were conducted in accordance with the University of
Queensland Animal Ethics Committee (approval no. MICRO/PARA/612/08/ARC).
DNA extraction and quantification. Overall, 30 mg of paired tumour and healthy
tissue from each individual koala (Supplementary Table 1) was extracted using the
Qiagen DNeasy® Blood and Tissue Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s protocol with the following modifications: the tissue was lysed
overnight for 15 h at 56 °C and hair was lysed for 48 h at 56 °C. The DNA con-
centration and quality was then determined using an Agilent Tapestation (Agilent
Technologies USA) with Genomic ScreenTapes and reagents.
Shearing of DNA and circularisation of fragmented DNA. The genomic DNA
for paired tumour and healthy tissues (Supplementary Table 1) was sheared to
between 3 and 4 kb using the Covaris™ M220 with miniTUBE Blue. All extracted
samples were fragmented using the following customised settings: intensity 0.1,
20% duty factor, 1000 cycles per burst, ten cycles at 20 s per cycle, temperature
20 °C. Where possible, 3 µg total DNA was fragmented and if not available, 1 µg
total DNA was used in a final volume of 100 µl. To find the optimal ligation
conditions for subsequent iPCR, we performed a series of ligations using a gradient
of (total) input blunt ended DNA. This consisted of three gradient points (20, 40
and 60 ng of total DNA) representing concentrations of 0.2, 0.4 and 0.6 ng/μl run
in triplicate 50 µl ligation reactions. Each ligation reaction was set up using a T4
DNA Ligase kit (5 U/µl) (Thermo Scientific) using 5 µl of T4 DNA ligase buffer
(10X), 5 µl of 50% PEG 4000 solution, 2.5 µl of T4 DNA ligase and molecular
biology grade water (Thermo Scientific). To reduce any sampling biases, each
sample was diluted down to a concentration of 10 ng/μl (as per TapeStation
readings) and the correct volume of DNA for each gradient point added accord-
ingly. A circularisation (non-template) water blank was also run in triplicate for all
samples. All circularisation reactions (samples and controls) were performed in
triplicate and then pooled.
Inverse PCR. A total of 10 ng from each of the circularised gradient points was
used as template for quadruplicate iPCR reactions. iPCR reactions were then
performed on all paired healthy and tumour tissue samples (fragmented and cir-
cularised) using the following LTR primers: forward 5′-ATT TGC ATC CGG AGT
TGT GT-3′ and reverse 5′-AGG GGC ACC CTA GAA ACT GT-3′. All primers are
listed in Supplementary Table 12. Each primer contained a unique 6 bp barcode
with additional three sacrificial nucleotide bases (to prevent loss of the barcode in
case of limited DNAse activity) at the 5′ end to enable identification in case samples
were later pooled for sequencing (although most samples were run in separate cells
on a PacBio RSII machine). All samples and controls were amplified using the
MyFi Mix (Bioline GmbH, Luckenwalde, Germany) using 50 µl of MyFi buffer (2X)
and a final 0.4 µM concentration of each indexed primer in a 100 µl volume.
Thermal cycling conditions were as follows: 95 °C for 1 min 30 s; followed by 30
cycles at 95 °C for 20 s, 57 °C for 30 s and 72 °C for 3 min. The iPCR products from
the quadruplicate reactions were pooled for each gradient point and purified using
the QIAquick PCR Purification Kit (Qiagen, Hilden, Germany). Concentrations
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Fig. 5 Overview of KoRV transformation processes in koalas. All northern koalas carry endogenous KoRVs (red koala images) which are subject to
Mendelian inheritance (purple arrow). Having multiple potentially active ERVs in every cell, with reintegration (blue arrows) leading to additional IS in
somatic cells (blue triangles), would confer a tremendous mutational load on the population. Both inherited and new somatic IS can potentially dysregulate
oncogenes, leading to an increased risk of transformation, with additional new integrations occurring in the transformed population of cells promoting
cancer and metastasis. The potential for KoRV to transduce oncogenes also increases cancer risk. Koalas without endogenous KoRV (grey koala images)
will only develop cancers (at a much lower rate) through other mechanisms.
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and DNA profiles were measured on the TapeStation and the optimal circular-
ization product from all sample-amplified gradients (20, 40 or 60 ng) was selected
by considering three criteria: (i) the DNA amount per microliter of iPCR product
in the 2–7 kb range, (ii) the average length distribution between 600 bp and 7 kb
range and (iii) the percentage of DNA within the 2–7 kb range. Only the optimal
circularisation gradient point for each sample was used for PacBio sequencing.
PacBio sequencing. The purified iPCR products from the healthy and tumour
tissues were processed by the Max Delbrück Center, Berlin, for PacBio library
construction and sequencing. Samples were individually purified using AMPure XP
beads (Beckman Coulter), at a concentration of 0.9X. Libraries were then created
for each sample using the PacBio (Pacific Biosciences, Menlo Park, CA) 5 kb
template preparation protocol and the SMRTbell™ Template Prep Kit 1.0 following
the manufacturer’s guidelines. The length and concentration of the libraries were
then determined with the 2100 Agilent Bioanalyzer using the 1200 DNA chemistry
(Agilent Technologies). Sequencing on the PacBio RSII platform was performed
using the MagBead Standard protocol, C4 chemistry and P6 polymerase on a single
v3 Single-Molecule Real-Time (SMRT) cell with 1 × 180 min movie for each
sample. Every sample was run across two Single-Molecule Real-Time (SMRT) cells
to increase the coverage and an extra sequencing run was done for Elise tumour
tissue (multiplexed with other samples) to further increase coverage. The reads
from the insert sequence were processed within the SMRT® Portal browser
(minimum full pass= 1; and a minimum predicted accuracy of 90).
Detecting IS from iPCR reads. Parts of the PacBio reads mapping to the KoRV-A
or KoRV-B genomes (GenBank: AB72100.1 and KC779547.1, respectively) were
identified using BLAST72 and removed so that only the koala genomic sequence
surrounding the insertion sites remained. The published koala genome (P. cinereus
release phaCin_unsw_v4.1, RefSeq assembly GCF_002099425.1) was also masked
for KoRV sequences. The trimmed reads were aligned to the masked koala genome
using BWA73 with the following parameters: BWA MEM –x pacbio –c 2500. The
results were filtered using Samtools74 to remove reads that failed platform/vendor
quality checks or were PCR duplicates. Matches longer than 50 bp with >90%
identity to the koala genome were retained. Retroviral IS have a distinct coverage
pattern from iPCR sequencing (Supplementary Fig. 2b). We used a stepwise
approach whereby: (i) high coverage IS with at least ten reads on each side were
identified (≥20× coverage at overlapping read starts/ends within a 10 bp window)
and corresponding reads removed from the dataset; (ii) low coverage insertion sites
(at least two reads on each side with at least five reads in total) were identified and
corresponding reads removed from the dataset and (iii) one-sided IS (where IS had
reads mapping only to either the upstream or downstream sequence) were iden-
tified from the remaining reads. The one-sided insertion sites were checked to see if
there were both sides (a start and end) within 10 kb, indicating that the published
koala genome also contained a KoRV at these positions or that there was an indel
in the koala genome between these positions. The level of sequencing allowed us to
reach almost full saturation of germline insertion sites in both tumour and healthy
tissues (Supplementary Fig. 3).
Comparing tumour and healthy samples. For each koala, the coordinates of the
IS from tumour tissue were compared to those from healthy tissue (using bedtools
merge from the Bedtools suite75) to find IS unique to one tissue and IS common to
both tissues. IS which overlapped or were within 10 bp of each (since the
boundaries of the IS can vary slightly due to alignments) were annotated as the
same IS. Scatter plots of insertion site coverage comparing tumour to healthy tissue
in each koala were generated.
PCR to confirm tumour-specific IS. Seven of the highest coverage IS specific to
tumour tissues were chosen for PCR confirmation. All primers are listed in Sup-
plementary Table 12. The large number and generally high frequency of flanking
sequences with large homopolymer stretches or skewed GC content precluded
designing primers for many tumour-specific integrations. Primers were designed
against the genomic region surrounding the IS (within 200 bp 5′ or 3′ of the IS).
For each IS, one koala genome primer and one LTR primer was used in order to
cross the IS (Supplementary Fig. 4a). The target sequence was amplified in the
following reaction: 12.5 µl of MyTaq™ HS Mix (Bioline, USA), 3.5 µl of PCR grade
water and 1.5 µl (10 mM) of IS specific primer and 1.5 µl (10 mM) or either forward
(5′-ATT TGC ATC CGG AGT TGT GT-3′) or reverse LTR (5′- AGG GGC ACC
CTA GAA ACT GT-3′) primers. The following thermocycling conditions were
used: (i) 95 °C for 5 min; (ii) 35 cycles, with 1 cycle consisting of 95 °C for 20 s,
60 °C for 20 s and 72 °C for 1 min and (iii) 72 °C for 2 min. The resulting amplicons
were Sanger sequenced at LGC Genomics (Germany) by primer walking and the
sequences checked using BLAST72 to compare them to the expected IS and adja-
cent KoRV LTRs.
Detection of KoRV variants. The env gene sequences from the KoRV variants
described in Chappell et al.14 (108 sequences from KoRV variants A, B, D, F, G, H,
I) were downloaded from NCBI and the most highly variable section from the
published sequence alignment was extracted (base 251 onwards). We used
BLAST72 with an e-value cut-off of 0.001 and minimum match length of 90 bp to
compare the variable region to all koala reads.
Annotation of insertion site locations and gene enrichment analyses. Bedtools
closest from the Bedtools suite75 was used to annotate the location of each IS with
reference to the koala transcriptome annotation (version 4.1). We took the closest
gene to each IS, regardless of whether sense or antisense strand. The gene set was
split into categories according to the category of the closest IS, namely: tumour
unique; healthy unique (unique to a single koala) and shared. The position of IS
relative to genes (distance 5′ or 3′, in exon, intron or UTR) was annotated.
We used Enrichr76,77 to detect any gene enrichments in KEGG pathways31 and
OMIM and DisGeNET33 disease gene sets (using Fisher’s exact test). Since these
enrichment analyses were carried out on human gene sets and not all human genes
are annotated in koala, we repeated the analysis on DisGeNET to check for any bias
as follows: the full DisGeNET gene sets were downloaded and only genes common
to human and koala were selected. The tmod package in R was used to perform a
hypergeometric test using the koala IS genes as the target set and the modified
DisGeNET sets as the background. The disease enrichments and P values were
compared to those from Enrichr and were found to be highly similar with the same
top enrichments. GO Ontology enrichments were carried out using GOrilla78 using
only genes common to human and koala in both target and background sets. We
downloaded five databases of cancer genes: Bushman Lab Cancer Gene List (http://
www.bushmanlab.org/links/genelists, v4 May 2018), harmonizome lymphoma79,
Intogen80, DriverDB81 and The Cancer Gene Atlas (TCGA)82. We used these to
detect cancer gene enrichments in the sets of genes closest to healthy tissue IS and
tumour-specific IS. For genes from TCGA (variants across 10,000 patients in 33
cancer types), only genes with variants found in > 500 individuals were used.
RNA Extraction and cDNA synthesis for quantitative PCR (qPCR). Overall,
30 mg of paired tumour and healthy tissue from each individual koala was
extracted using Qiagen RNeasy® Mini Kit (Qiagen, Hilden, Germany) with the
RNase-Free DNase Set. The following modifications were made to the manu-
facturer’s protocol: tissues were lysed using 600 µl RTL buffer and the Precellys 24
Tissue Homogenizer. cDNA was then generated from the extracted rRNA using the
Invitrogen SuperScript® IV Kit (Thermo Fisher Scientific, USA) following the
manufacturer’s instructions; two reactions per sample were performed. Second
strand synthesis was then carried out by adding 1 µl of Klenow DNA polymerase I
(Thermo Fisher Scientific, USA) to 21 µl of cDNA and incubated at 37 °C for
60 min followed by 75 °C for 20 min. The cDNA was the quantified using the
Agilent Tapestation (Agilent Technologies, USA) using D1000 ScreenTapes and
reagents.
Selecting genes for qPCR. From the six koalas that had available tissue for
expression analysis, we chose the three koalas with the largest numbers of tumour-
specific insertion sites for qPCR analysis. The list of IS was ordered by the read
coverage (as very low coverage may indicate that the insertion site is not in many
cells in the tissue). Insertion sites were excluded if only one side of the insertion site
was covered by reads. We selected genes where the insertion site was in an intron
(as we make the assumption that this gene will be most affected by any promoter
effects). We excluded genes which had putative annotations or were of unknown
function.
To choose regions for primer design, we used the koala transcriptome
annotation to select consecutive exons that were present in all predicted transcript
variants of each gene to avoid alternative splicing events. In case of any errors in
the koala genome annotation, we used Blastx to compare these exons to the
SWISSPROT/TREMBL database to select exons which are conserved in other
species at the protein level. Forward and reverse primers were placed in
consecutive exons.
Gene expression using qPCR. To assess gene expression levels, SYBR green based
comparative CT (ΔΔCT) and qPCR were employed. Koalas selected were those that
had tissue samples from liver and/or lymph node so that expression levels could be
measured in the same tissue between koalas. Two additional koalas from outside
this study (Bilyarra and Mirali) were also included as controls. Expression levels of
seven genes in healthy and tumour tissues were assessed. The samples tested in
each case were: (i) tumour tissue from koala with IS in gene of interest; (ii) tumour
tissue from koalas without IS in gene of interest and (iii) healthy tissue. Primer
concentrations were optimised according to the manufacturer’s protocol. All pri-
mers are listed in Supplementary Table 12. Overall, 100 ng of cDNA from both
tumour and healthy tissues were run in triplicate reactions for each primer set in
addition to negative controls and housekeeping gene controls. The target gene was
amplified using the following reaction: 0.5 µM of the forward and reverse primer,
12.5 µl SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich, USA), 0.25 µl
reference dye (ROX) and 10 µl of template cDNA. The PCR was carried out in 96-
well plates using the Stratagene MX3000P System (Agilent Technologies, USA) and
StepOnePlus instruments under the following cycling conditions: 94 °C for 2 min,
followed by 40 cycles, with 1 cycle consisting of 94 °C for 15 s and 60 °C for 1 min.
GAPDH was run as a housekeeping gene. For all koalas, ΔCT were calculated by
subtracting the CT value of GAPDH from the test gene CT value. Gene expression
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values were normalised (ΔΔCT) by subtracting the ΔCT of Bilyarra’s healthy tis-
sues. The fold difference was then taken as 2−ΔΔCT83.
Analysis of shared IS. PCA was performed on a matrix of IS versus koalas for all
IS in healthy tissues using the R package logisticPCA for dimensionality reduction
of binary data. Clustering was performed using hclust in R with a binary distance
matrix. Geographic distances between koalas were calculated as the shortest
straight line between locations. A Mantel test of distance versus number of shared
IS was performed in R using the ade4 library.
Expression of SLC29A1 and ZFAT. Data were downloaded from the European
Read Archive (Project numbers PRJEB21505 and PRJEB26467, respectively). Reads
were trimmed using BBduk from BBTools (https://sourceforge.net/projects/
bbmap/) and aligned to the koala reference genome (RefSeq assembly
GCF_002099425.1) using STAR84. Reads were counted using htseq-count85 and
differential expression was analysed using the R package Limma86, with sex and
disease status included as factors in the model. As a further check for SLC29A1, the
expression was normalised using the expression of the housekeeping gene GAPDH
in the samples but the difference in expression between northern and southern
koalas remained.
Retrovirus transduction discovery. The transduced BCL2L1 was discovered
because reads mapping to this gene had an unusual coverage pattern where the
reads mapped precisely to the exons, ending at the exon boundaries. From the full-
length reads, the fusion of BCL2L1 within the KoRV env gene was apparent and,
additionally, a fragment of the 3′ UTR of the gene ZBTB18 was also detected in the
gag gene. All koala samples were subsequently searched for this fusion using
BLAST and six koalas (Elise, Lisa, Bonnie, Ralf, A30038 and A31756) were checked
using PCR. All primers are listed in Supplementary Table 12. The band from PCR
of Elise was Sanger sequenced.
All samples were also scanned for any other reads which mapped precisely to
exons, but none were found. Integrations sites for the transduced virus were
identified by selecting the reads containing to the BCL2L1 fusion and removing any
parts matching the BCL2L1 fusion sequence. BLAST72 was used to find where the
remaining parts of the reads mapped in the koala genome.
Distribution of IS in koala genome. To assess if IS were distributed in a random
fashion, we performed 1000 randomizations of IS coordinates using bedtools
shuffle75 and calculated the numbers of IS located within 10 kb. We then per-
formed a chi-squared test for 2 × 2 contingency tables comparing real IS to random
IS on number of single IS in 10 kb compared with number of two or more IS
within 10 kb.
Finding statistically significant hotspots of IS. We implemented a Monte Carlo
simulation following a method used to find common insertion sites in a retroviral
tagging study38. We used bedtools shuffle75 to generate 10,000 randomisations of
the IS across the koala genome. For windows of varying sizes (2, 10, 30, 50, 100,
200, 300 and 400 kb), we counted the number windows containing a given number
of IS (2–10). Also, since a random distribution of IS in the genome follows a
Poisson distribution, we calculated the Poisson probability for each window size
containing two or more IS and corrected for number of windows tested.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Sequence data that support the findings of this study are deposited in the NCBI Short
Read Archive under BioProject PRJNA587467. The remaining data are available within
the article, Supplementary Information or available from the authors upon request.
Received: 29 April 2020; Accepted: 1 February 2021;
References
1. Lee, A., Nolan, A., Watson, J. & Tristem, M. Identification of an ancient
endogenous retrovirus, predating the divergence of the placental mammals.
Philos. Trans. R. Soc. Lond. B Biol. Sci. 368, 20120503 (2013).
2. Sokol, M., Wabl, M., Ruiz, I. R. & Pedersen, F. S. Novel principles of gamma-
retroviral insertional transcription activation in murine leukemia virus-
induced end-stage tumors. Retrovirology 11, 36 (2014).
3. Biswas, H. H. et al. Increased all-cause and cancer mortality in HTLV-II
infection. J. Acquir. Immune Defic. Syndr. 54, 290–296 (2010).
4. Tsatsanis, C. et al. Genetic determinants of feline leukemia virus-induced
lymphoid tumors: patterns of proviral insertion and gene rearrangement. J.
Virol. 68, 8296–8303 (1994).
5. Nellaker, C. et al. The genomic landscape shaped by selection on transposable
elements across 18 mouse strains. Genome Biol. 13, R45 (2012).
6. Richoux, V., Panthier, J. J., Salmon, A. M. & Condamine, H. Acquisition of
endogenous ecotropic MuLV can occur before the late one-cell stage in the
genital tract of SWR/J-RF/J hybrid females. J. Exp. Zool. 252, 96–100 (1989).
7. Holt, M. P., Shevach, E. M. & Punkosdy, G. A. Endogenous mouse mammary
tumor viruses (mtv): new roles for an old virus in cancer, infection, and
immunity. Front. Oncol. 3, 287 (2013).
8. Stoye, J. P., Moroni, C. & Coffin, J. M. Virological events leading to
spontaneous AKR thymomas. J. Virol. 65, 1273–1285 (1991).
9. Lober, U. et al. Degradation and remobilization of endogenous retroviruses by
recombination during the earliest stages of a germ-line invasion. Proc. Natl
Acad. Sci. USA 115, 8609–8614 (2018).
10. Ishida, Y., Zhao, K., Greenwood, A. D. & Roca, A. L. Proliferation of
endogenous retroviruses in the early stages of a host germ line invasion. Mol.
Biol. Evol. 32, 109–120 (2015).
11. Stocking, C. & Kozak, C. A. Murine endogenous retroviruses. Cell Mol. Life
Sci. 65, 3383–3398 (2008).
12. Tarlinton, R. E., Meers, J. & Young, P. R. Retroviral invasion of the koala
genome. Nature 442, 79–81 (2006).
13. Simmons, G. S. et al. Prevalence of koala retrovirus in geographically diverse
populations in Australia. Aust. Vet. J. 90, 404–409 (2012).
14. Chappell, K. J. et al. Phylogenetic diversity of koala retrovirus within a wild
koala population. J. Virol. 91, e01820–16 (2017).
15. Xu, W. et al. An exogenous retrovirus isolated from koalas with malignant
neoplasias in a US zoo. Proc Natl Acad Sci USA 110, 11547–11552 (2013).
16. Shojima, T. et al. Identification of a novel subgroup of koala retrovirus from
koalas in Japanese zoos. J. Virol. 87, 9943–9948 (2013).
17. Quigley, B. L., Ong, V. A., Hanger, J. & Timms, P. Molecular dynamics and
mode of transmission of koala retrovirus as it invades and spreads through a
wild Queensland koala population. J. Virol. 92, e01871–17 (2018).
18. McDougall, A. S. et al. Defective endogenous proviruses are expressed in feline
lymphoid cells: evidence for a role in natural resistance to subgroup B feline
leukemia viruses. J. Virol. 68, 2151–2160 (1994).
19. Hanger, J. J., Bromham, L. D., McKee, J. J., O’Brien, T. M. & Robinson, W. F.
The nucleotide sequence of koala (Phascolarctos cinereus) retrovirus: a novel
type C endogenous virus related to gibbon ape leukemia virus. J. Virol. 74,
4264–4272 (2000).
20. Gonzalez-Astudillo, V. et al. A necropsy study of disease and comorbidity
trends in morbidity and mortality in the koala (Phascolarctos cinereus) in
South-East Queensland, Australia. Sci. Rep. 9, 17494 (2019).
21. Fabijan, J. et al. Pathological findings in koala retrovirus-positive koalas
(Phascolarctos cinereus) from Northern and Southern Australia. J. Comp.
Pathol. 176, 50–66 (2020).
22. Gillett, A. K. An examination of disease in captive Australian koalas
(Phascolarctos cinereus) and potential links to koala retrovirus (KoRV). Tech.
Rep. Aust. Mus. Online 24, 39–45 (2014).
23. Sarker, N. et al. Koala retrovirus viral load and disease burden in distinct
northern and southern koala populations. Sci. Rep. 10, 263 (2020).
24. Alquezar-Planas, D. E. et al. DNA sonication inverse PCR for genome scale
analysis of uncharacterized flanking sequences. Methods Ecol. Evol. 12,
182–195 (2020).
25. Johnson, R. N. et al. Adaptation and conservation insights from the koala
genome. Nat. Genet. 50, 1102–1111 (2018).
26. Hobbs, M. et al. Long-read genome sequence assembly provides insight into
ongoing retroviral invasion of the koala germline. Sci. Rep. 7, 15838 (2017).
27. Hobbs, M. et al. A transcriptome resource for the koala (Phascolarctos
cinereus): insights into koala retrovirus transcription and sequence diversity.
BMC Genom. 15, 786 (2014).
28. Jenkins, N. A. & Copeland, N. G. High frequency germline acquisition of
ecotropic MuLV proviruses in SWR/J-RF/J hybrid mice. Cell 43, 811–819
(1985).
29. Quigley, B. L. et al. Changes in endogenous and exogenous koala retrovirus
subtype expression over time reflect koala health outcomes. J. Virol. 93,
e00849–19 (2019).
30. Babaei, S., Akhtar, W., de Jong, J., Reinders, M. & de Ridder, J. 3D hotspots of
recurrent retroviral insertions reveal long-range interactions with cancer
genes. Nat. Commun. 6, 6381 (2015).
31. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 28, 27–30 (2000).
32. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The
Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000).
33. Pinero, J. et al. DisGeNET: a comprehensive platform integrating information
on human disease-associated genes and variants. Nucleic Acids Res. 45,
D833–D839 (2017).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21612-7 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:1316 | https://doi.org/10.1038/s41467-021-21612-7 |www.nature.com/naturecommunications 11
34. Desfarges, S. & Ciuffi, A. Retroviral integration site selection. Viruses 2,
111–130 (2010).
35. Sharma, A. et al. BET proteins promote efficient murine leukemia virus
integration at transcription start sites. Proc. Natl Acad. Sci. USA 110,
12036–12041 (2013).
36. Sarker, N. et al. Identification of stable reference genes for quantitative PCR in
koalas. Sci. Rep. 8, 3364 (2018).
37. Maldarelli, F. et al. HIV latency. Specific HIV integration sites are linked to
clonal expansion and persistence of infected cells. Science 345, 179–183
(2014).
38. Suzuki, T. et al. New genes involved in cancer identified by retroviral tagging.
Nat. Genet. 32, 166–174 (2002).
39. Swanstrom, R., Parker, R. C., Varmus, H. E. & Bishop, J. M. Transduction of a
cellular oncogene: the genesis of Rous sarcoma virus. Proc. Natl Acad. Sci.
USA 80, 2519–2523 (1983).
40. Ruscetti, S. K. Deregulation of erythropoiesis by the Friend spleen focus-
forming virus. Int J. Biochem. Cell Biol. 31, 1089–1109 (1999).
41. Boise, L. H. et al. Bcl-X, a Bcl-2-related gene that functions as a dominant
regulator of apoptotic cell death. Cell 74, 597–608 (1993).
42. Schott, A. F., Apel, I. J., Nunez, G. & Clarke, M. F. Bcl-X(L) protects cancer-
cells from P53-mediated apoptosis. Oncogene 11, 1389–1394 (1995).
43. Trisciuoglio, D. et al. BCL-XL overexpression promotes tumor progression-
associated properties. Cell Death Dis. 8, 3216 (2017).
44. Kasaian, K. et al. The genomic and transcriptomic landscape of anaplastic
thyroid cancer: implications for therapy. BMC Cancer 15, 984 (2015).
45. Klaassen, C. D. & Lu, H. Xenobiotic transporters: ascribing function from
gene knockout and mutation studies. Toxicol. Sci. 101, 186–196 (2008).
46. Choi, D. S. et al. The type 1 equilibrative nucleoside transporter regulates
ethanol intoxication and preference. Nat. Neurosci. 7, 855–861 (2004).
47. Tsunoda, T. & Shirasawa, S. Roles of ZFAT in haematopoiesis, angiogenesis
and cancer development. Anticancer Res. 33, 2833–2837 (2013).
48. Kresse, S. H. et al. LSAMP, a novel candidate tumor suppressor gene in
human osteosarcomas, identified by array comparative genomic hybridization.
Genes Chromosomes Cancer 48, 679–693 (2009).
49. Jiang, X. et al. Deregulated expression in Ph+ human leukemias of AHI-1, a
gene activated by insertional mutagenesis in mouse models of leukemia. Blood
103, 3897–3904 (2004).
50. Johansson, F. K., Goransson, H. & Westermark, B. Expression analysis of
genes involved in brain tumor progression driven by retroviral insertional
mutagenesis in mice. Oncogene 24, 3896–3905 (2005).
51. Clark, C. R. et al. Transposon mutagenesis screen in mice identifies TM9SF2
as a novel colorectal cancer oncogene. Sci. Rep. 8, 15327 (2018).
52. Touw, I. P. & Erkeland, S. J. Retroviral insertion mutagenesis in mice as a
comparative oncogenomics tool to identify disease genes in human leukemia.
Mol. Ther. 15, 13–19 (2007).
53. Ringrose, A. et al. Evidence for an oncogenic role of AHI-1 in Sezary
syndrome, a leukemic variant of human cutaneous T-cell lymphomas.
Leukemia 20, 1593–1601 (2006).
54. Erkeland, S. J. et al. Large-scale identification of disease genes involved in
acute myeloid leukemia. J. Virol. 78, 1971–1980 (2004).
55. Kriajevska, M. et al. Liprin beta 1, a member of the family of LAR
transmembrane tyrosine phosphatase-interacting proteins, is a new target for
the metastasis-associated protein S100A4 (Mts1). J. Biol. Chem. 277,
5229–5235 (2002).
56. Rozeman, L. B. et al. Array-comparative genomic hybridization of central
chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent
kinase 4 as candidate target genes for genomic aberrations. Cancer 107,
380–388 (2006).
57. Li, Y. et al. SPOCK1 is regulated by CHD1L and blocks apoptosis and
promotes HCC cell invasiveness and metastasis in mice. Gastroenterology 144,
179–191 (2013).
58. Shu, Y. J. et al. SPOCK1 as a potential cancer prognostic marker promotes the
proliferation and metastasis of gallbladder cancer cells by activating the PI3K/
AKT pathway. Mol. Cancer 14, 12 (2015).
59. Wang, Y., Wang, W. & Qiu, E. SPOCK1 promotes the growth of osteosarcoma
cells through mTOR-S6K signaling pathway. Biomed. Pharmacother. 95,
564–570 (2017).
60. Slack, G. W. & Gascoyne, R. D. MYC and aggressive B-cell lymphomas. Adv.
Anat. Pathol. 18, 219–228 (2011).
61. Nakano, K., Uchimaru, K., Utsunomiya, A., Yamaguchi, K. & Watanabe, T.
Dysregulation of c-Myb pathway by aberrant expression of proto-oncogene
MYB provides the basis for malignancy in adult T-cell leukemia/lymphoma
cells. Clin. Cancer Res. 22, 5915–5928 (2016).
62. Carter, A. J. & Nguyen, A. Q. Antagonistic pleiotropy as a widespread
mechanism for the maintenance of polymorphic disease alleles. BMC Med.
Genet. 12, 160 (2011).
63. Shen, H. et al. The human knockout gene CLYBL connects itaconate to
vitamin B12. Cell 171, 771–B782 (2017).
64. Lecube, A. et al. Proteomic analysis of cerebrospinal fluid from obese women
with idiopathic intracranial hypertension: a new approach for identifying new
candidates in the pathogenesis of obesity. J. Neuroendocrinol. 24, 944–952
(2012).
65. Wang, H. et al. Hypothalamic Ahi1 mediates feeding behavior through
interaction with 5-HT2C receptor. J. Biol. Chem. 287, 2237–2246 (2012).
66. Norrmen, C. et al. Liprin (beta)1 is highly expressed in lymphatic vasculature
and is important for lymphatic vessel integrity. Blood 115, 906–909 (2010).
67. Zheng, H. et al. Koala retrovirus diversity, transmissibility, and disease
associations. Retrovirology 17, 34 (2020).
68. Subramanian, R. P., Wildschutte, J. H., Russo, C. & Coffin, J. M. Identification,
characterization, and comparative genomic distribution of the HERV-K
(HML-2) group of human endogenous retroviruses. Retrovirology 8, 90 (2011).
69. Yu, T. et al. The piRNA response to retroviral invasion of the koala genome.
Cell 179, 632–643 (2019).
70. Ito, J., Gifford, R. J. & Sato, K. Retroviruses drive the rapid evolution of
mammalian APOBEC3 genes. Proc. Natl Acad. Sci. USA 117, 610–618 (2020).
71. Dunn-Fletcher, C. E. et al. Anthropoid primate-specific retroviral element
THE1B controls expression of CRH in placenta and alters gestation length.
PLoS Biol. 16, e2006337 (2018).
72. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local
alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
73. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-
Wheeler transform. Bioinformatics 26, 589–595 (2010).
74. Li, H. et al. The Sequence Alignment/Map format and SAMtools.
Bioinformatics 25, 2078–2079 (2009).
75. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for
comparing genomic features. Bioinformatics 26, 841–842 (2010).
76. Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list
enrichment analysis tool. BMC Bioinform. 14, 128 (2013).
77. Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis
web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).
78. Eden, E., Navon, R., Steinfeld, I., Lipson, D. & Yakhini, Z. GOrilla: a tool for
discovery and visualization of enriched GO terms in ranked gene lists. BMC
Bioinform. 10, 48 (2009).
79. Rouillard, A. D. et al. The harmonizome: a collection of processed datasets
gathered to serve and mine knowledge about genes and proteins. Database
2016, baw100 (2016).
80. Gonzalez-Perez, A. et al. IntOGen-mutations identifies cancer drivers across
tumor types. Nat. Methods 10, 1081–1082 (2013).
81. Cheng, W. C. et al. DriverDB: an exome sequencing database for cancer driver
gene identification. Nucleic Acids Res. 42, D1048–D1054 (2014).
82. Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification
of 10,000 tumors from 33 types of cancer. Cell 173, 291–304 (2018).
83. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25,
402–408 (2001).
84. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29,
15–21 (2013).
85. Anders, S., Pyl, P. T. & Huber, W. HTSeq–a Python framework to work with
high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
86. Phipson, B., Lee, S., Majewski, I. J., Alexander, W. S. & Smyth, G. K. Robust
hyperparameter estimation protects against hypervariable genes and improves
power to detect differential expression. Ann. Appl. Stat. 10, 946–963 (2016).
Acknowledgements
The authors thank Karin Hönig and Nick Peters for technical assistance. A.D.G. and
G.K.M. were supported by grant GR 3924/15-1 from the Deutsche For-
schungsgemeinschaft (DFG). D.E.A.-P. and A.D.G. were supported by the Morris Animal
Foundation, Grant D14ZO-94. D.E.A.-P. was supported by a postdoctoral fellowship of
the Deutscher Akademischer Austauschdienst, Grant 2014 57129705. A.L.R. and A.D.G.
were supported by Grant R01GM092706 from the National Institute of General Medical
Sciences (NIGMS). The content is solely the responsibility of the authors and does not
necessarily represent the official views of the NIGMS or the National Institutes of Health.
Author contributions
A.D.G. and G.K.M. conceived and designed the study; G.K.M. conceived and performed
the analysis; D.E.A.-P. optimised and performed experiments for detecting integration
sites; A.D. performed experiments; A.G. carried out koala pathology and sample col-
lection; K.J.C., P.T. and P.R.Y. provided samples; J.H. provided data on koala can-
cer prevalence; R.T., N.M., M.T. and A.L.R. provided expert opinions, advice and
discussions, and contributed to writing of the manuscript; G.K.M., R.T., A.L.R. and
A.D.G. wrote the manuscript. All authors reviewed and approved the final version.
Competing interests
The authors declare no competing interests.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21612-7
12 NATURE COMMUNICATIONS |         (2021) 12:1316 | https://doi.org/10.1038/s41467-021-21612-7 | www.nature.com/naturecommunications
Additional information
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s41467-021-21612-7.
Correspondence and requests for materials should be addressed to A.D.G.
Peer review information Nature Communications thanks Michael J. Metzger and the
other, anonymous reviewer(s) for their contribution to the peer review of this work.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adaptation,
distribution and reproduction in any medium or format, as long as you give appropriate
credit to the original author(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made. The images or other third party material in
this article are included in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s Creative
Commons license and your intended use is not permitted by statutory regulation or
exceeds the permitted use, you will need to obtain permission directly from the copyright
holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2021
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21612-7 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:1316 | https://doi.org/10.1038/s41467-021-21612-7 |www.nature.com/naturecommunications 13
